Actinium Pharmaceuticals shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Actinium Pharmaceuticals (ATNM) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Actinium Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Actinium Pharmaceuticals held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Actinium Pharmaceuticals by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-03-31 | $124k | 77k | 1.61 |
| 2024-12-31 | $171k | 135k | 1.26 |
| 2024-09-30 | $172k | 91k | 1.88 |
| 2024-06-30 | $298k | 40k | 7.40 |
| 2024-03-31 | $87k | 11k | 7.83 |
| 2023-12-31 | $79k | 16k | 5.08 |
| 2023-09-30 | $274k | 46k | 5.92 |
| 2023-06-30 | $103k | 14k | 7.42 |
| 2023-03-31 | $880k | 93k | 9.45 |
| 2022-12-31 | $108k | 10k | 10.65 |